Clinical Evaluation of Duchenne Muscular Dystrophy Severity Using Ultrasound Small-Window Entropy Imaging
Open Access
- 27 June 2020
- Vol. 22 (7), 715
- https://doi.org/10.3390/e22070715
Abstract
Information entropy of ultrasound imaging recently receives much attention in the diagnosis of Duchenne muscular dystrophy (DMD). DMD is the most common muscular disorder; patients lose their ambulation in the later stages of the disease. Ultrasound imaging enables routine examinations and the follow-up of patients with DMD. Conventionally, the probability distribution of the received backscattered echo signals can be described using statistical models for ultrasound parametric imaging to characterize muscle tissue. Small-window entropy imaging is an efficient nonmodel-based approach to analyzing the backscattered statistical properties. This study explored the feasibility of using ultrasound small-window entropy imaging in evaluating the severity of DMD. A total of 85 participants were recruited. For each patient, ultrasound scans of the gastrocnemius were performed to acquire raw image data for B-mode and small-window entropy imaging, which were compared with clinical diagnoses of DMD by using the receiver operating characteristic curve. The results indicated that entropy imaging can visualize changes in the information uncertainty of ultrasound backscattered signals. The median with interquartile range (IQR) of the entropy value was 4.99 (IQR: 4.98–5.00) for the control group, 5.04 (IQR: 5.01–5.05) for stage 1 patients, 5.07 (IQR: 5.06–5.07) for stage 2 patients, and 5.07 (IQR: 5.06–5.07) for stage 3 patients. The diagnostic accuracies were 89.41%, 87.06%, and 72.94% for ≥stage 1, ≥stage 2, and ≥stage 3, respectively. Comparisons with previous studies revealed that the small-window entropy imaging technique exhibits higher diagnostic performance than conventional methods. Its further development is recommended for potential use in clinical evaluations and the follow-up of patients with DMD.Funding Information
- Ministry of Science and Technology, Taiwan (106-2221-E-182-023-MY3)
This publication has 39 references indexed in Scilit:
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management (vol 17, pg 251, 2018)The Lancet Neurology, 2018
- The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence reviewOrphanet Journal of Rare Diseases, 2017
- Advances in genetic therapeutic strategies for Duchenne muscular dystrophyExperimental Physiology, 2015
- Prevalence of Duchenne and Becker Muscular Dystrophies in the United StatesPEDIATRICS, 2015
- Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)European Journal of Human Genetics, 2013
- Evidence‐based path to newborn screening for duchenne muscular dystrophyAnnals of Neurology, 2012
- The muscular dystrophiesThe Lancet, 2002
- Duchenne muscular dystrophy—Meryon's diseaseNeuromuscular Disorders, 1993
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987
- Management of end stage respiratory failure in duchenne muscular dystrophyMuscle & Nerve, 1987